JFS Wealth Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $411 | Hold |
13
| – | – | ﹤0.01% | 1730 |
|
2025
Q1 | $432 | Hold |
13
| – | – | ﹤0.01% | 1786 |
|
2024
Q4 | $448 | Buy |
13
+2
| +18% | +$69 | ﹤0.01% | 1794 |
|
2024
Q3 | $440 | Hold |
11
| – | – | ﹤0.01% | 1817 |
|
2024
Q2 | $332 | Buy |
11
+7
| +175% | +$211 | ﹤0.01% | 1852 |
|
2024
Q1 | $135 | Buy |
4
+2
| +100% | +$68 | ﹤0.01% | 1926 |
|
2023
Q4 | $65 | Sell |
2
-8
| -80% | -$260 | ﹤0.01% | 1970 |
|
2023
Q3 | $328 | Sell |
10
-1
| -9% | -$33 | ﹤0.01% | 1806 |
|
2023
Q2 | $388 | Buy |
11
+4
| +57% | +$141 | ﹤0.01% | 1794 |
|
2023
Q1 | $229 | Sell |
7
-7
| -50% | -$229 | ﹤0.01% | 1812 |
|
2022
Q4 | $771 | Buy |
14
+5
| +56% | +$275 | ﹤0.01% | 1657 |
|
2022
Q3 | $0 | Buy |
9
+1
| +13% | – | ﹤0.01% | 1813 |
|
2022
Q2 | $0 | Buy |
8
+1
| +14% | – | ﹤0.01% | 1830 |
|
2022
Q1 | $0 | Buy |
7
+6
| +600% | – | ﹤0.01% | 1886 |
|
2021
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1784 |
|